Home Oncology Immunotherapies

Immunotherapies

Latest
Body with stomach tumor
Immunotherapies

FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer

Epic Sciences has added simultaneous microsatellite instability and chromosomal instability analyses to its cancer immunotherapy NGS workflowfor clinical research of cancer immunotherapies. [Source: Rita Elena Serda
Immunotherapies

Study Highlights Patients at Risk For Severe Cancer Immunotherapy Side Effects

ersonal Genome Diagnostics (PGDx) said today that its 500+ gene pan-cancer tumor profiling tissue assay is being used by Merck & Co. in a Phase II clinical trial designed to assess patient response to a dual biomarker-directed precision oncology combination therapy in patients with previously untreated advanced non-small cell lung cancer (NSCLC).
Immunotherapies

Synlogic Unveils Promising Safety Data on its Immunotherapy Drug at AACR

Bladder Cancer
Immunotherapies

Genes Linked to Immunotherapy Resistance in Bladder Cancer Uncovered

3D rendering of a therapeutic antibody molecule binding to PD-1 protein
Immunotherapies

High Tumor Mutation Burden Only Useful Prognosis Predictor for Some Cancers

brain tumor
Immunotherapies

CSF Test Predicts Brain Cancer Response to Immunotherapies

Genetic test
Immunotherapies

Strata Oncology, Pfizer Collaborate on Biomarker Driven Trial to Re-Target Approved...

Immunotherapies

Columbia, MIT Researchers Provide New Insights of Immune Checkpoint Therapy Resistance

Brain tumor illustration
Immunotherapies

Immunotherapy Target Identified for Brain Cancer, with Potential for Other Tumors...

T cell attacking a cancer cell
Immunotherapies

Inherited Genetic Variation Plays Role in Immune Response to Cancer Treatment

Load more

New Products

View More
Load more
Copyright © 2020 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up